Daniel Marti‐Morente

Daniel Marti‐Morente

Auto-generated profile, based on publicly available information

Daniel Marti‐Morente

Department of Immunology Hospital Clínic Barcelona, Universitat de Barcelona (UB) Barcelona Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MTMaria Tamayo
Maria Tamayo
LMLaura Martín-Nunes
Laura Martín-Nunes
MPMaría José Piedras
María José Piedras
MCMaria Martin Calvo
Maria Martin Calvo
DMDaniel Martí-Morente
Daniel Martí-Morente
CDCarmen Delgado
Carmen Delgado
Adverse ventricular remodeling is the heart’s response to damaging stimuli and is linked to heart failure and poor prognosis. Formyl-indolo [3,2-b] carbazole (FICZ) is an endogenous ligand for the aryl hydrocarbon receptor (AhR), through which it exerts pleiotropic effects including protection against inflammation, fibrosis, and oxidative stress. We evaluated the effect of AhR activation by FICZ on the adverse ventricular remodeling that occurs in the early phase of pressure overload in the murine heart induced by transverse aortic constriction (TAC). Cardiac structure and function were evaluated by cardiac magnetic resonance imaging (CMRI) before and 3 days after Sham or TAC surgery in mice treated with FICZ or with vehicle, and cardiac tissue was used for biochemical studies. CMRI analysis revealed that FICZ improved cardiac function and attenuated cardiac hypertrophy. These beneficial effects involved the inhibition of the hypertrophic calcineurin/NFAT pathway, transcriptional reduction in pro-fibrotic genes, and antioxidant effects mediated by the NRF2/NQO1 pathway. Overall, our findings provide new insight into the role of cardiac AhR signaling in the injured heart.

12 June 2025 in Allergy
Verified
Journal Article
Open access
DLD. Loli‐Ausejo
D. Loli‐Ausejo
MGM. F. Gonzalez‐Matamala
M. F. Gonzalez‐Matamala
DMD. Martí
D. Martí
MRM. Ruano‐Zaragoza
M. Ruano‐Zaragoza
PIPatricia Mir Ihara
Patricia Mir Ihara
RMRosa Muñoz-Cano
Rosa Muñoz-Cano

13 October 2022 in HLA
Verified
Journal Article
Closed access
JBJennifer Bolaños
Jennifer Bolaños
DLDaniel Lorca‐Arce
Daniel Lorca‐Arce
CPCristina Arnaldos Pérez
Cristina Arnaldos Pérez
DMDaniel Marti‐Morente
Daniel Marti‐Morente
CSCarles Serra‐Pages
Carles Serra‐Pages

13 March 2023 in HLA
Verified
Journal Article
Open access
DLDaniel Lorca‐Arce
Daniel Lorca‐Arce
DMDaniel Marti‐Morente
Daniel Marti‐Morente
CPCristina Arnaldos Pérez
Cristina Arnaldos Pérez
JBJennifer Bolaños
Jennifer Bolaños
CSCarles Serra‐Pages
Carles Serra‐Pages
A novel HLA‐DRB1*04 allele, officially designated HLA‐DRB1*04:361, was identified by next‐generation sequencing.

18 December 2024
Verified
Preprint
Open access
PDF file
DLDavid Loli-Ausejo
David Loli-Ausejo
GMGonzalez-Matamala Mf
Gonzalez-Matamala Mf
DMDaniel Martí
Daniel Martí
MRMaria Ruano-Zaragoza
Maria Ruano-Zaragoza
PIPatricia Mir Ihara
Patricia Mir Ihara
RMRosa Muñoz-Cano
Rosa Muñoz-Cano
REAL-LIFE INSIGHTS AND CLINICAL CHARACTERISTICS OF HEREDITARY ALPHA TRYPTASEMIA IN ANAPHYLACTIC PATIENTSAuthors: Loli-Ausejo D1,2,4*, Gonzalez-Matamala MF1,2*, Martí D3, Ruano-Zaragoza M1,2,4, Mir-Ihara P1,2,4, Solis-Ynga K1,2, Lara R3, Bartra J1,2,4, Pascal M2,3,4**, Muñoz-Cano R 1,2,4**1. Department of Allergy, Hospital Clinic Barcelona, Universitat de Barcelona (UB), Barcelona, Spain.2. Clinical and Experimental Respiratory Immunoallergy (IRCE), Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.3. Department of Immunology, Hospital Clínic Barcelona, Universitat de Barcelona (UB), Barcelona, Spain.4. Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), Red de Enfermedades Inflamatorias (REI), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.* Loli-Ausejo D and Gonzalez-Matamala MF contributed equally to this work** Pascal M and Muñoz-Cano R contributed equally to this workCorrespondance : rmunoz@clinic.cat